| References |
Top |
| REF 1 |
The PcG protein hPc2 interacts with the N-terminus of histone demethylase JARID1B and acts as a transcriptional co-repressor. BMB Rep. 2009 Mar 31;42(3):154-9.
|
| REF 2 |
SUMOylation negatively modulates target gene occupancy of the KDM5B, a histone lysine demethylase. Epigenetics. 2013 Nov;8(11):1162-75.
|
| REF 3 |
Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesis. Proc Natl Acad Sci U S A. 2011 May 3;108(18):7541-6.
|
| REF 4 |
Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. Cancer Res. 2011 Nov 1;71(21):6899-908.
|
| REF 5 |
Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases. Int J Cancer. 2007 Jul 15;121(2):265-75.
|
| REF 6 |
Human PLU-1 Has transcriptional repression properties and interacts with the developmental transcription factors BF-1 and PAX9. J Biol Chem. 2003 Jun 6;278(23):20507-13.
|
| REF 7 |
RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells. Int J Cancer. 2008 Mar 1;122(5):1047-57.
|
| REF 8 |
CDX2-driven leukemogenesis involves KLF4 repression and deregulated PPAR signaling. J Clin Invest. 2013 Jan;123(1):299-314.
|
